Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 2,435 | 1,820 | 374 | 325 | 282 |
| Gross Profit | 2,435 | 1,820 | 374 | 325 | 282 |
| Operating Expenses | 11,209 | 14,641 | 15,542 | 14,536 | 16,371 |
| Operating Income | -8,774 | -12,821 | -15,168 | -14,211 | -16,089 |
| Interest Expense | 0 | 0 | 24 | 0 | 46 |
| Other Income | 46 | 93 | 191 | 248 | 521 |
| Pre-tax Income | -8,728 | -12,728 | -15,001 | -13,963 | -15,614 |
| Net Income Continuous | -8,728 | -12,728 | -15,001 | -13,963 | -15,614 |
| Net Income | $-8,728 | $-12,728 | $-15,001 | $-13,963 | $-15,614 |
| EPS Basic Total Ops | -0.23 | -0.34 | -0.40 | -0.38 | -0.42 |
| EPS Basic Continuous Ops | -0.23 | -0.34 | -0.40 | -0.38 | -0.42 |
| EPS Diluted Total Ops | -0.23 | -0.34 | -0.40 | -0.38 | -0.42 |
| EPS Diluted Continuous Ops | -0.23 | -0.34 | -0.40 | -0.38 | -0.42 |
| EBITDA(a) | $-8,555 | $-12,598 | $-14,943 | $-13,715 | $-15,309 |